Quest Diagnostics Incorporated
DGX
$234.40
-$1.64-0.70%
NYSE
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 9.87% | 11.03% | 11.78% | 13.74% | 12.58% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 9.87% | 11.03% | 11.78% | 13.74% | 12.58% |
| Cost of Revenue | 9.92% | 10.70% | 11.52% | 12.94% | 12.26% |
| Gross Profit | 9.75% | 11.69% | 12.30% | 15.37% | 13.24% |
| SG&A Expenses | 9.22% | 11.21% | 10.92% | 12.49% | 12.81% |
| Depreciation & Amortization | 2.72% | 10.95% | 21.26% | 31.62% | 31.25% |
| Other Operating Expenses | 0.00% | -250.00% | -200.00% | 150.00% | -- |
| Total Operating Expenses | 9.66% | 10.74% | 11.52% | 13.16% | 12.62% |
| Operating Income | 11.06% | 12.70% | 13.34% | 17.31% | 12.35% |
| Income Before Tax | 10.83% | 15.65% | 13.90% | 16.92% | 13.62% |
| Income Tax Expenses | 10.73% | 23.68% | 15.02% | 22.86% | 16.53% |
| Earnings from Continuing Operations | 10.86% | 13.40% | 13.57% | 15.28% | 12.81% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 5.56% | 0.00% | -8.00% | -16.33% | -8.00% |
| Net Income | 11.79% | 14.16% | 13.89% | 15.22% | 13.10% |
| EBIT | 11.06% | 12.70% | 13.34% | 17.31% | 12.35% |
| EBITDA | 9.94% | 12.42% | 13.93% | 17.98% | 14.24% |
| EPS Basic | 12.51% | 14.34% | 13.81% | 14.87% | 13.00% |
| Normalized Basic EPS | 14.42% | 14.32% | 12.56% | 11.89% | 7.95% |
| EPS Diluted | 12.62% | 14.20% | 13.57% | 15.74% | 13.90% |
| Normalized Diluted EPS | 14.65% | 14.56% | 12.59% | 11.44% | 7.75% |
| Average Basic Shares Outstanding | -0.45% | 0.00% | 0.22% | 0.00% | 0.00% |
| Average Diluted Shares Outstanding | -0.66% | -0.22% | 0.22% | 0.44% | 0.22% |
| Dividend Per Share | 7.10% | 6.89% | 6.67% | 6.42% | 6.16% |
| Payout Ratio | -0.05% | -0.07% | -0.06% | -0.08% | -0.06% |